Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Nuclear Cardiology
Erschienen in: Journal of Nuclear Cardiology 4/2010

01.08.2010 | Review Article

The clinical utility of assessing myocardial blood flow using positron emission tomography

verfasst von: Maria Cecilia Ziadi, MD, Rob S. B. Beanlands, MD, FRCPC, FACC

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Excerpt

The physiology of myocardial blood flow (MBF), tracers and methods for quantification using positron emission tomography (PET) are detailed in the reviews by Schelbert and deKemp.1,2 Here, we focus on the potential clinical utility of flow and will discuss: (1) why consider flow quantification and why use PET; (2) keys to establishing utility; (3) tabulate a classification of diseases where flow quantification may be of use; (4) review data on the prognostic value of flow quantification; (5) discuss the benefits of Rubidium (82Rb) for flow quantification as a widely available tracer; (6) review the potential of new 18Fluoride-labeled agents; and (7) review case examples where flow may aid in patient management. …
Literatur
1.
deKemp RA, Beanlands RS, Yoshinaga K. Will 3-dimensional PET-CT enable the routine quantification of myocardial blood flow? J Nucl Cardiol 2007;14:380-97.CrossRefPubMed
2.
Schelbert HR. Quantification of myocardial blood flow: What is the clinical role? Cardiol Clin 2009;27:277-89.CrossRefPubMed
3.
Camici PG, Rimoldi OE. The clinical value of myocardial blood flow measurement. J Nucl Med 2009;50:1076-87.CrossRefPubMed
4.
Parkash R, deKemp RA, Ruddy TD, et al. Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol 2004;11:440-9.CrossRefPubMed
5.
Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.CrossRefPubMed
6.
Shikama N, Himi T, Yoshida K, et al. Prognostic utility of myocardial blood flow assessed by N-13 ammonia positron emission tomography in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 1999;84:434-9.CrossRefPubMed
7.
Olivotto I, Cecchi F, Camici PG, et al. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1043-8.CrossRefPubMed
8.
Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.CrossRefPubMed
9.
Herzog BA, Husmann L, Valenta I, et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography: Added value of coronary flow reserve. J Am Coll Cardiol 2009;54:150-6.CrossRefPubMed
10.
Ziadi MC, deKemp RA, Beanlands RSB. Quantification of myocardial perfusion: What will it take to make it to prime time? Curr Cardiovas Imag Rep 2009;2:238-49.CrossRef
11.
Chareonthaitawee P, Kaufmann PA, Camici PG, et al. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res 2001;50:151-61.CrossRefPubMed
12.
Lortie M, Beanlands RSB, deKemp RA, Yoshinaga K, et al. Quantification of myocardial blood flow with 82-Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging 2007;34:1765-74.CrossRefPubMed
13.
Uren NG, Camici P, Melin JA, et al. Effect of aging on myocardial perfusion reserve. J Nuci Med 1995;36:2032-6.
14.
Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.PubMed
15.
Dilsizian V, MD, Bacharach S, Beanlands RSB, Schelbert HR, et al. ASNC Imaging Guidelines for Nuclear Cardiology Procedures. PET myocardial perfusion and metabolism clinical imaging, July 2009. Available at: http://​www.​asnc.​org.
16.
Geltman EM, Henes CG, Senneff MJ, et al. Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries. J Am Coll Cardiol 1990;16:596-8.CrossRef
17.
Nesterov SV, Han C, Lisinen I, Ukkonen H, Knuuti J, et al. Myocardial perfusion quantitation with 15O-water PET: High reproducibility of the new cardiac analysis software (Carimas™). Eur J Nucl Med Mol Imag 2009;36:1594-602.CrossRef
18.
Ziadi MC, deKemp RA, Guo A, Williams W, Beanlands RSB, et al. Impaired myocardial flow reserve measured using rubidium-82 PET predicts outcomes in patients with suspected myocardial ischemia. Circulation 2009;120:S320 (abstract 325).
19.
Dayanikli F, Grambow D, Muzik O, et al. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 1994;90:808-17.PubMed
20.
Kaufmann PA, Gnecchi-Ruscone T, di Camici PG, et al. Coronary heart disease in smokers: Vitamin C restores coronary microcirculatory function. Circulation 2000;102:1233-8.PubMed
21.
Brush JE Jr, Cannon RO III, Schenke WH, et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-7.PubMed
22.
Di Carli MF, Dorbala S, Curillova Z, Kwong R, et al. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol 2007;14:799-809.CrossRefPubMed
23.
Sampson UK, Di Carli MF, Dorbala S, Kwong R, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol 2007;49:1052-8.CrossRefPubMed
24.
Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974;33:87-94.CrossRefPubMed
25.
Gould KL. Quantification of coronary artery stenosis in vivo. Circ Res 1985;57:341-53.PubMed
26.
Uren NG, Melin JA, De Bruyne B, Camici PG. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med 1994;330:1782-8.CrossRefPubMed
27.
Beanlands RS, Hutchins GD, Schwaiger M, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography: Determination of extent of altered vascular reactivity. J Am Coll Cardiol 1995;26:1465-75.CrossRefPubMed
28.
Di Carli M, Czernin J, Gerbaudo VH, Schelbert HR, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.PubMed
29.
Tonino PA, De Bruyne B, Fearon WF, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. The FAME Study Investigators. N Eng J Med 2009;360:213-24.CrossRef
30.
Hajjiri MM, Leavitt MB, Gewirtz H, et al. Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. J Am Coll Cardiol Imag 2009;2:751-8.
31.
Curillova Z, Yaman BF, Dorbala S, Di Carli MF, et al. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imag 2009;36:1603-10.CrossRef
32.
Tio R, van Veldhuisen DJ, Zijlstra F, Slart RH, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med 2009;50:214-9.CrossRefPubMed
33.
Knaapen P, Germans T, Camici PG, et al. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;294:H986-93.CrossRefPubMed
34.
Neglia D, Parodi O, Gallopin M, Pratali L, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 1995;92:796-804.PubMed
35.
Canetti M, Akhter MW, Lerman A, et al. Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol 2003;92:1246-9.CrossRefPubMed
36.
Goldstein RA, Kirkeeide RL, Demer LL, Mullani NA, Gould KL, et al. Changes in myocardial perfusion reserve after PTCA: Noninvasive assessment with positron tomography. J Nucl Med 1987;28:1262-7.PubMed
37.
Yoshinaga K, Chow BJ, deKemp RA, Beanlands R, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol 2006;48:1029-39.CrossRefPubMed
38.
Lertsburapa K, Ahlberg AW, Bateman TM, Heller GV, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2008;15:745-53.PubMed
39.
Dorbala S, Hachamovitch R, Kwong RY, Di Carli MF, et al. Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. JACC Cardiovasc Imaging 2009;2:846-54.CrossRefPubMed
40.
Lautamaki R, George RT, Kitagawa K, Voicu C, et al. Rubidium-82 PET-CT for quantitative assessment of myocardial blood flow: Validation in a canine model of coronary artery stenosis. Eur J Nucl Med Mol Imaging 2009;36:576-86.CrossRefPubMed
41.
El Fakhri G, Dorbala S, Di Carli MF, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with 82Rb PET: Comparison with 13N-ammonia PET. J Nucl Med 2009;50:1062-71.CrossRefPubMed
42.
Anagnostopoulos C, Dorbala S, Di Carli MF, et al. Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity. Eur J Nucl Med Mol Imaging 2008;35:1593-601.CrossRefPubMed
43.
Ziadi MC, deKemp RA, Guo A, Beanlands RSB, et al. Reduced myocardial flow reserve quantified with rubidium-82 PET is an independent predictor of three vessel coronary artery disease. Circulation 2009;120:S320-1 (abstract 327).
44.
Madar I, Ravert HT, Du Y, et al. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med 2006;47:1359-66.PubMed
45.
Madar I, Ravert H, DiPaula A, et al. Assessment of severity of coronary artery stenosis in a canine model using the PET agent 18F-fluorobenzyl triphenyl phosphonium: Comparison with 99mTc tetrofosmin. J Nucl Med 2007;48:1021-30.CrossRefPubMed
46.
Yu M, Guaraldi M, Mistry M, et al. BMS.747158-02: A novel PET myocardial perfusion imaging agent. J Nucl Cardiol 2007;14:789-98.CrossRefPubMed
47.
Maddahi J, Schiepers C, Czernin J, Richard Sparks R, Phelps M, et al. First human study of BMS747158, a novel F-18 labeled tracer for myocardial perfusion imaging. J Nucl Med 2007;49:70P (abstract).
48.
Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart 2008;94:360-7.CrossRefPubMed
49.
Camici PG, Crea F. Coronary microvascular dysfunction. N Eng J Med 2007;356:830-40.CrossRef
Metadaten
Titel
The clinical utility of assessing myocardial blood flow using positron emission tomography
verfasst von
Maria Cecilia Ziadi, MD
Rob S. B. Beanlands, MD, FRCPC, FACC
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 4/2010
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-010-9258-7

Weitere Artikel der Ausgabe 4/2010

Journal of Nuclear Cardiology 4/2010 Zur Ausgabe

Nuclear Cardiology Bullet

Evaluation of coronary artery aneurysm and stenosis using open-source myocardial perfusion SPECT and coronary computed tomographic angiography image fusion software

Original Article

Blunted heart rate response as a predictor of cardiac death in patients undergoing vasodilator stress technetium-99m sestamibi gated SPECT myocardial perfusion imaging

Editor's Page

The case for cardiac magnetic resonance and positron emission tomography multimodality imaging of myocardial viability

Symposium

Noninvasive quantification of myocardial blood flow and coronary flow reserve

Editorial

Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications

Original Article

Cardiac imaging and safety evaluation of BMS747158, a novel PET myocardial perfusion imaging agent, in chronic myocardial compromised rabbits

Neu im Fachgebiet Kardiologie

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise